Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
9.87
+0.12 (1.23%)
Oct 8, 2026, 3:25 PM EDT - Market open

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,4611,9501,8693,3522,0762,419
Market Cap Growth
337.41%4.33%-44.23%61.49%-14.18%-
Enterprise Value
11,3322,5522,7593,8822,6762,681
Last Close Price
9.751.982.565.025.076.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
61.8217.22126.775388.888648.472589.53
PB Ratio
--3.90-3.83-5.72-4.61-9.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
67.0722.53187.096241.2011149.272870.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.17-1.69-1.62-1.51-1.61-2.66
Net Debt / Equity Ratio
-0.83-1.20-1.31-1.05-1.37-1.35
Net Debt / EBITDA Ratio
-3.70-2.50-1.96-1.80-1.86-1.09
Net Debt / FCF Ratio
-3.02-1.95-1.61-1.55-1.48-1.07
Asset Turnover
0.320.260.030.000.000.00
Inventory Turnover
0.260.16----
Quick Ratio
5.364.622.784.630.220.86
Current Ratio
5.725.103.365.050.280.91
Return on Assets (ROA)
-30.54%-36.17%-48.48%-52.11%-52.73%-57.48%
Return on Capital Employed (ROCE)
-45.60%-58.20%-104.90%-81.00%253.20%-317.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.68%-18.02%-22.13%-17.40%-20.07%-14.34%
FCF Yield
-2.81%-15.83%-21.30%-11.85%-20.03%-12.73%
Buyback Yield / Dilution
-26.61%-31.33%-37.71%-27.19%-2.74%-3.23%
SEC Filings: 10-K · 10-Q